A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Clinical trial NCT02759107 · COMPLETED

Trial details

NCT number: NCT02759107
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Type 2 Diabetes Mellitus (T2DM)

Start date: 2016-05-11
Primary completion: 2017-06-26
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.